Elevated estimated pulmonary artery systolic pressure is associated with an adverse clinical outcome in patients receiving cardiac resynchronization therapy

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 5, 2007, Pages 603-607

  Stern, Joshua ^a   Heist, E Kevin ^a   Murray, Lorne ^a   Alabiad, Chrisfouad ^a   Chung, Jeffrey ^a   Picard, Michael H ^a   Semigran, Marc J ^a   Ruskin, Jeremy N ^a   Singh, Jagmeet P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cardiac pacing; Cardiac resynchronization therapy; Heart failure; Pulmonary hypertension

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; QRS COMPLEX; RETROSPECTIVE STUDY; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION; TREATMENT RESPONSE;

AGED; CARDIAC PACING, ARTIFICIAL; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION, PULMONARY; MALE; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 34247466481     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00719.x     Document Type: Article

References (15)

1. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 352 : 1539 1549.
2. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, Kass DA, et al. Cardiac resynchronization and death from progressive heart failure: A meta-analysis of randomized controlled trials. JAMA 2003 289 : 730 740.
3. Yu CM, Fung JWH, Zhang Q, Sanderson JE. Understanding nonresponders of cardiac resynchronization therapy - Current and future perspectives. J Cardiovasc Electrophysiol 2005 16 : 1117 1124.
4. St John Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology. Circulation 2006 113 : 266 272.
5. Grzybowski J, Bilinska ZT, Ruzyllo W, Kupsc Q, Michalak E, Szczesniewska D, Poplawska W, et al. Determinants of prognosis in nonischemic dilated cardiomyopathy. J Card Fail 1996 2 : 77 85.
6. Abramson SV, Burke JF, Kelly JJ, Kitchen JG, Dougherty MJ, Yih DF, McGeehin FC, et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 1992 116 : 888 895.
7. Yu CM, Bleeker GB, Fung JW, Schalij MJ, Zhang Q, Van Der Wall EE, Chan YS, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005 112 : 1580 1586.
8. Tedrow UB, Kramer DB, Stevenson LW, Stevenson WG, Baughman KL, Epstein LM, Lewis EF. Relation of right ventricular peak systolic pressure to major adverse events in patients undergoing cardiac resynchronization therapy. Am J Cardiol 2006 97 : 1737 1740.
9. Leclercq C, Cazeau S, Le Breton H, Ritter P, Mabo P, Gras D, Pavin D, et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998 32 : 1825 1831.
10. Brieke A, DeNofrio D. Right ventricular dysfunction in chronic dilated cardiomyopathy and heart failure. Coron Artery Dis 2005 16 : 5 11.
11. Chin KM, Kim NHS, Rubin LJ. The right ventricle in pulmonary hypertension. Coron Artery Dis 2005 16 : 13 18.
12. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini E, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001 37 : 183 188.
13. Knuuti J, Sundell J, Naum A, Engblom E, Koistinen J, Ylitalo A, Stolen KQ, et al. Assessment of right ventricular oxidative metabolism by PET in patients with idiopathic dilated cardiomyopathy undergoing cardiac resynchronization therapy. Eur J Nucl Med Mol Imaging 2004 31 : 1592 1598.
14. Brieke A, DeNofrio D. Right ventricular dysfunction in chronic dilated cardiomyopathy and heart failure. Coron Artery Dis 2005 16 : 5 11.
15. Sandoval J, Bauerle O, Palomar A, Gomez A, Martinez-Guerra ML, Beltran M, Guerrero ML. Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation 1994 89 : 1733 1744.